• No se han encontrado resultados

por microondas y su evaluación biológica

preparado 8-aril guanosinas monofosfato (I, 8-aril-GMP) 31 o trifosfato (III, 8-aril-GTP)

5.4. Estudios de fluorescencia

5.4.2 Ensayo frente a PNP de Plasmodium falciparum

El curso de la reacción de fosforolisis se siguió al acoplarla a una reacción de xantinoxidasa, que cataliza la oxidación de hipoxantina a ácido úrico y cuya formación se puede seguir a 293nm (coeficiente de extinción molar para el ácido úrico: 12.9 mM-1

cm-1). Para determinar la actividad inhibitoria se incubó una mezcla que contenía

KH2PO4 (50 mM, pH 7.5), xantinaoxidasa (60mU), PfPNP (0.73mg, 25nM) e inosina

(25 M) en un volumen final de 1 mL a 25 ºC. Para los estudios de inhibición, se llevaron a cabo varios experimentos en donde la concentración de inhibidor era variable (5 concentraciones fueron ensayadas) y la concentración de inosina fija (25 M).

Todos los espectros se registraron a una concentración 50 µM en PBS a partir de una disolución stock 5 mM en DMSO. Todas las medidas se realizaron en celdas de cuarzo de paso óptico 10 mm. La rendija de excitación se fijó a 15 nm y la de emisión a 20 nm, y los espectros fueron registrados en un intervalo de 1 nm y con una velocidad de barrido de 100 nm por minuto.

Una mezcla que contiene 50 mM KH2PO4 pH 7.5, 268 nM (7.83mg) PfPNP y 0.5 mM

de nucleósido se incubó a temperatura ambiente entre 30min y 2 horas, y se registraron los espectros de fluorescencia ( ex = 288nm; em = 300-450nm). Como controles se

6. BIBLIOGRAFÍA

(1) Thomsen, N. M.; Vongsutilers, V.; Gannett, P. The synthesis of C8-aryl purines, nucleosides and phosphoramidites. Crit Rev Eukaryot Gen Expr 2011, 21, 155– 176.

(2) Hung, M. H.; Stock, L. M. Reactions of benzenediazonium ions with guanine and its derivatives. J Org Chem 1982, 47, 448–453.

(3) Chin, A.; Hung, M. H.; Stock, L. M. Reactions of benzenediazonium ions with adenine and its derivatives. J Org Chem 1981, 46, 2203–2207.

(4) Gannett, P. M.; Lawson, T.; Miller, M.; Thakkar, D. D.; Lord, J. W.; Yau, W. M.; Toth, B. 8-Arylguanine adducts from arenediazonium ions and DNA. Chem Biol Interact 1996, 101, 149–164.

(5) Arsenyan, P.; Ikaunieks, M.; Belyakov, S. Stille coupling approaches for the synthesis of 8-aryl guanines. Tetrahedron Lett 2007, 48, 961–964.

(6) K. Vollmann, C. E. M. Synthesis of 8-substituted xanthine derivatives by Suzuki cross-coupling reaction. Heterocycles 2002, 57, 871–879.

(7) Mayer, E.; Valis, L.; Huber, R.; Amann, N.; Wagenknecht, H. A. Preparation of pyrene- modified purine and pyrimidine nucleosides via Suzuki-Miyaura cross- couplings and characterization of their fluorescent properties. Synthesis 2003, 2003, 2335–2340.

(8) Capek, P.; Pohl, R.; Hocek, M. Cross-coupling reactions of unprotected halopurine bases, nucleosides, nucleotides and nucleoside triphosphates with 4- boronophenylalanine in water. Synthesis of (purin-8-yl)- and (purin-6- yl)phenylalanines. Org Biomol Chem 2006, 4, 2278–2284.

(9) Western, E. C.; Shaughnessy, K. H. Inhibitory effects of the guanine moiety on Suzuki couplings of unprotected halonucleosides in aqueous media. J Org Chem 2005, 70, 6378–6388.

(10) Western, E. C.; Daft, J. R.; Johnson, E. M.; Gannett, P. M.; Shaughnessy, K. H. Efficient one-step Suzuki arylation of unprotected halonucleosides, using water- soluble palladium catalysts. J Org Chem 2003, 68, 6767–6774.

(11) Meng, X.; Moriuchi, T.; Kawahata, M.; Yamaguchi, K.; Hirao, T. A G-octamer scaffold via self-assembly of a guanosine-based Au(I) isonitrile complex for Au(I)- Au(I) interaction. Chem Commun 2011, 47, 4682–4684.

(12) Gurram, V.; Pottabathini, N.; Garlapati, R.; Chaudhary, A. B.; Patro, B.; Lakshman, M. K. C-C cross-coupling reactions of O6-alkyl-2-haloinosine derivatives and a one-pot cross-coupling/O6-deprotection procedure. Chem Asian J 2012, 7, 1853–1861.

(13) Cerna, I.; Pohl, R.; Hocek, M. Direct C-H arylation of purines: development of methodology and its use in regioselective synthesis of 2,6,8-trisubstituted purines. Org Lett 2006, 8, 5389–5392.

(14) Cerna, I.; Pohl, R.; Klepetárová, B.; Hocek, M. Synthesis of 6,8,9-tri- and 2,6,8,9- tetrasubstituted purines by a combination of the Suzuki cross-coupling, N- arylation, and direct C-H arylation reactions. J Org Chem 2008, 73, 9048–9054. (15) Cerna, I.; Pohl, R.; Hocek, M. The first direct C-H arylation of purine nucleosides.

Chem Commun 2007, 45, 4729–4730.

(16) Storr, T. E.; Firth, A. G.; Wilson, K.; Darley, K.; Baumann, C. G.; Fairlamb, I. J. S. Site-selective direct arylation of unprotected adenine nucleosides mediated by palladium and copper: insights into the reaction mechanism. Tetrahedron 2008, 64, 6125–6137.

(17) Storr, T. E.; Baumann, C. G.; Thatcher, R. J.; De Ornellas, S.; Whitwood, A. C.; Fairlamb, I. J. S. Pd(0)/Cu(I)-mediated direct arylation of 2’-deoxyadenosines: mechanistic role of Cu(I) and reactivity comparisons with related purine nucleosides. J Org Chem 2009, 74, 5810–5821.

(18) Uesugi, S.; Ikehara, M. Carbon-13 magnetic resonance spectra of 8-substituted purine nucleosides. Characteristic shifts for the syn conformation. J Am Chem Soc 1977, 99, 3250–3253.

(19) Nair, V.; Young, D. A. Conformational correlation of purine nucleosides by high- field carbon-13 NMR data. Magn Reson Chem 1987, 25, 937–940.

(20) Vongsutilers, V.; Phillips, D. J.; Train, B. C.; Mckelvey, G. R.; Thomsen, N. M.; Shaughnessy, K. H.; Lewis, J. P.; Gannett, P. M. The conformational effect of para-substituted C8-arylguanine adducts on the B/Z-DNA equilibrium. Biophys Chem 2011, 154, 41–48.

(21) Dai, J.; Sloat, A. L.; Wright, M. W.; Manderville, R. A. Role of phenoxyl radicals in DNA adduction by chlorophenol xenobiotics following peroxidase activation. Chem Res Toxicol 2005, 18, 771–779.

(22) Witham, A. A.; Beach, D. G.; Gabryelski, W.; Manderville, R. A. Hydroxyl radical- induced oxidation of a phenolic C-linked 2’-deoxyguanosine adduct yields a reactive catechol. Chem Res Toxicol 2012, 25, 315–325.

(23) Dai, Q.; Xu, D.; Lim, K.; Harvey, R. G. Efficient syntheses of C(8)-aryl adducts of adenine and guanine formed by reaction of radical cation metabolites of carcinogenic polycyclic aromatic hydrocarbons with DNA. J Org Chem 2007, 72, 4856–4863.

(24) Millen, A. L.; Manderville, R. A.; Wetmore, S. D. Conformational flexibility of C8- phenoxyl-2’-deoxyguanosine nucleotide adducts. J Phys Chem B 2010, 114, 4373–4382.

(25) Valis, L. E.; Mayer, E. E.; Wagenknecht, H. A. 8-(Pyren-1-yl)-2’-deoxyguanosine as an optical probe for DNA hybridization and for charge transfer with small peptides. Bioorg Med Chem Lett 2006, 16, 3184–3187.

(26) Storr, T. E.; Strohmeier, J. A.; Baumann, C. G.; Fairlamb, I. J. S. A sequential direct arylation/Suzuki-Miyaura cross-coupling transformation of unprotected 2’- deoxyadenosine affords a novel class of fluorescent analogues. Chem Commun 2010, 46, 6470–6472.

(27) Kim, D.; Jun, H.; Lee, H.; Hong, S. S.; Hong, S. Development of new fluorescent xanthines as kinase inhibitors. Org Lett 2010, 12, 1212–1215.

(28) Sinkeldam, R. W.; Greco, N. J.; Tor, Y. Fluorescent analogs of biomolecular building blocks: design, properties, and applications. Chem Rev 2010, 110, 2579– 25619.

(29) Rankin, K. M.; Sproviero, M.; Rankin, K.; Sharma, P.; Wetmore, S. D.; Manderville, R. A. C8-heteroaryl-2’-deoxyguanosine adducts as conformational fluorescent probes in the NarI recognition sequence. J Org Chem 2012, 77, 10498–10508.

(30) Collier, A.; Wagner, G. K. A fast synthetic route to GDP-sugars modified at the nucleobase. Chem Commun 2008, 2, 178–180.

(31) Collier, A.; Wagner, G. A facile two-step synthesis of 8-arylated guanosine mono- and triphosphates (8-aryl GXPs). Org Biomol Chem 2006, 4, 4526–4532.

(32) Läppchen, T.; Pinas, V. A.; Hartog, A. F.; Koomen, G. J.; Schaffner-Barbero, C.; Andreu, J. M.; Trambaiolo, D.; Löwe, J.; Juhem, A.; Popov, A. V; Blaauwen, T. Probing FtsZ and tubulin with C8-substituted GTP analogs reveals differences in their nucleotide binding sites. Chem Biol 2008, 15, 189–199.

(33) Bhaumik, D.; Medin, J.; Gathy, K.; Coleman, M. S. Mutational analysis of active site residues of human adenosine deaminase. J Biol Chem 1993, 268, 5464– 5470.

(34) Mills, G. C.; Schmalstieg, F. C.; Trimmer, K. B.; Goldman, A. S.; Goldblum, R. M. Purine metabolism in adenosine deaminase deficiency. Proc Natl Acad Sci USA 1976, 73, 2867–2871.

(35) Jie-ying, L.; Thakur, S. A.; Zalinger, Z. B.; Gerrish, K. E.; Imani, F. Inosine- containing RNA is a novel innate immune recognition element and reduces RSV infection. PLoS One 2011, 6, e26463.

(36) Chung, D. H.; Strouse, J. J.; Sun, Y.; Arterburn, J. B.; Parker, W. B.; Jonsson, C. B. Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine. Antiviral Res 2009, 83, 80–85.

(37) Signorelli, K. L.; Hadden, J. W. T cell immunostimulation by methyl inosine 5’- monophosphate: application to infectious diseases. Int Immunopharmacol 2003, 3, 1177–1186.

(38) Liekens, S.; Hernández, A. I.; Ribatti, D.; De Clercq, E.; Camarasa, M. J.; Pérez- Pérez, M. J.; Balzarini, J. The nucleoside derivative 5’-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action. J Biol Chem 2004, 279, 29598–29605.

(39) Liekens, S.; Bronckaers, A.; Hernández, A. I.; Priego, E. M.; Casanova, E.; Camarasa, M. J.; Pérez-Pérez, M. J.; Balzarini, J. 5’-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis. Mol Pharmacol 2006, 70, 501–509.

(40) Casanova, E.; Hernandez, A. I.; Priego, E. M.; Liekens, S.; Camarasa, M. J.; Balzarini, J.; Pérez-Pérez, M. J. 5’-O-Tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase. J Med Chem 2006, 49, 5562–5570. (41) Liekens, S.; Bronckaers, A.; Belleri, M.; Bugatti, A.; Sienaert, R.; Ribatti, D.; Nico,

B.; Gigante, A.; Casanova, E.; Opdenakker, G.; Pérez-Pérez, M. J.; Balzarini, J.; Presta, M. The thymidine phosphorylase inhibitor 5’-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist. Mol Cancer Ther 2012, 11, 817–829.

(42) Koellner, G.; Lui , M.; Shugar, D.; Saenger, W.; Bzowska, A. Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 Å resolution. J Mol Biol 1997, 265, 202–216.

(43) Sahnoun, S.; Messaoudi, S.; Peyrat, J. F.; Brion, J. D.; Alami, M. Microwave- assisted Pd(OH)2-catalyzed direct C H arylation of free-(NH2) adenines with aryl halides. Tetrahedron Lett 2008, 49, 7279–7283.

(44) Gaetke, L. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003, 189, 147–163.

(45) Kennedy, D. C.; McKay, C. S.; Legault, M. C. B.; Danielson, D. C.; Blake, J.; Pegoraro, A. F.; Stolow, A.; Mester, Z.; Pezacki, J. P. Cellular consequences of copper complexes used to catalyze bioorthogonal click reactions. J Am Chem Soc 2011, 133, 17993–18001.

(46) Lallana, E.; Riguera, R.; Fernandez-Megia, E. Reliable and efficient procedures for the conjugation of biomolecules through Huisgen azide-alkyne cycloadditions. Angew Chem Int Ed 2011, 50, 8794–8804.

(47) Vanková, B.; Krchnák, V.; Soural, M.; Hlavác, J. Direct C-H arylation of purine on solid phase and its use for chemical libraries synthesis. ACS Comb Sci 2011, 13, 496–500.

(48) Cui, H.; Ruda, G. F.; Carrero-Lérida, J.; Ruiz-Pérez, L. M.; Gilbert, I. H.; González- Pacanowska, D. Exploring new inhibitors of Plasmodium falciparum purine nucleoside phosphorylase. Eur J Med Chem 2010, 45, 5140–5149.

(49) Cassera, M. B.; Hazleton, K. Z.; Merino, E. F.; Obaldia, N.; Ho, M.-C.; Murkin, A. S.; DePinto, R.; Gutierrez, J. A.; Almo, S. C.; Evans, G. B.; Babu, Y. S.; Schramm, V. L. Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model. PLoS One 2011, 6, e26916.

(50) Pergolizzi, G.; Butt, J. N.; Bowater, R. P.; Wagner, G. K. A novel fluorescent probe for NAD-consuming enzymes. Chem Commun 2011, 47, 12655–12657.

Capítu o 3

Enfermedades vira es emergentes: